4-cholesten-3-one Suppresses Lung Adenocarcinoma Metastasis by Regulating Translocation of HMGB1, HIF1α and Caveolin-1
Overview
General Medicine
Authors
Affiliations
Metastasis is a great challenge in lung adenocarcinoma (ADC) therapy. Cholesterol has been implicated in ADC metastasis. 4-cholesten-3-one, as cholesterol metabolite and analog, can substitute membrane cholesterol and increase membrane fluidity. In this study, we explored the possibility that 4-cholesten-3-one inhibited ADC metastasis. Low-dose 4-cholesten-3-one significantly restrained ADC cells migration and invasion with little effects on cells viabilities. Further investigation showed that 4-cholesten-3-one promoted ROS generation, which transiently activated AMPKα1, increased HIF1α expression, reduced Bcl-2 expression and caused autophagy. AMPKα1 knockdown partly suppressed 4-cholesten-3-one-induced autophagy but, neither prevented 4-cholesten-3-one-induced upregulation of HIF1α or downregulation of Bcl-2. 4-cholesten-3-one-induced autophagy facilitated the release of HMGB1 from nuclei to cytoplasm, blocking nuclear translocation of HIF1α and activation of MMP2 and MMP9. Also, 4-cholesten-3-one induced time-dependent phosphorylation of caveolin-1, Akt and NF-κB. With increasing treatment time, 4-cholesten-3-one accelerated caveolin-1 internalization, but reduced the phosphorylation of Akt and NF-κB, and inhibited the expression of snail and twist. These data suggested that 4-cholesten-3-one could be a potential candidate for anti-metastasis of lung adenocarcinoma.
Cai R, Li X, Liang H, Chen S, Huang Y, Chai H Molecules. 2025; 30(3).
PMID: 39942825 PMC: 11821128. DOI: 10.3390/molecules30030722.
Shen L, Yang Z, Zhong Y, Bi Y, Yu J, Lu Q Adv Sci (Weinh). 2024; 12(5):e2406975.
PMID: 39664002 PMC: 11791989. DOI: 10.1002/advs.202406975.
Jain N, Tailang M, Chandrasekaran B, Khazaleh N, Thangavel N, Makeen H Front Pharmacol. 2024; 15:1290398.
PMID: 38505421 PMC: 10949534. DOI: 10.3389/fphar.2024.1290398.
Yang W, Wu W, Zhao Y, Li Y, Zhang C, Zhang J Cell Biol Int. 2022; 46(12):2060-2074.
PMID: 36054154 PMC: 9826031. DOI: 10.1002/cbin.11890.
Metabolities from Marine Sponges of the Genus : Occurrence, Biological Activity, and NMR Data.
Nogueira de Sousa L, de Araujo R, Sousa-Fontoura D, Menezes F, Araujo R Mar Drugs. 2021; 19(12).
PMID: 34940662 PMC: 8706505. DOI: 10.3390/md19120663.